JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 654-660

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real‐Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia‐negative chronic myeloproliferative neoplasms

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 6, 2015-12 ,pp. : 766-773

John Wiley & Sons Inc

Access to resources Recommend Favorite

The JAK2 V617F mutation: no impact on circulating hematopoietic progenitors in myeloproliferative disorders

By Wappl Michaela  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 509-511

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders

By Basquiera Ana L.   Soria Néstor W.   Ryser Ricardo   Salguero Miriam   Moiraghi Beatriz   Sackmann Federico   Sturich Ana G.   Borello Adriana   Berretta Adriana   Bonafé Miriam   Barral José Moreno   Palazzo Emilio D.   García Juan J.  

Hematology, Vol. 14, Iss. 6, 2009-12 ,pp. : 323-330

Maney Publishing

Access to resources Recommend Favorite

A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms

By Fantasia Francesca   Capua Emma   Cenfra Natalia   Pessina Gloria   Mecarocci Sergio   Rago Angela   Cotroneo Ettore   Busanello Anna   Equitani Francesco   Lo-Coco Francesco   Nervi Clara   Cimino Giuseppe  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 609-616

Springer Publishing Company

Access to resources Recommend Favorite